InMed Pharmaceuticals Profile

0.3193
USD 0.01  3.24%
0.32Last Month High 0.41 
0.31Trading Day  High 0.33 

InMed Pharmaceuticals Summary

InMed Pharmaceuticals Inc (IMLFF) is traded on OTC Market in USA. It is located in Vancouver, BC VC T and employs 6 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 44.44 M. InMed Pharmaceuticals Inc has 113.84 M outstanding shares. INMED PHARMACEUTI has accumulated about 2.25 M in cash with (1.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Check InMed Pharmaceuticals Probability Of Bankruptcy

InMed Pharmaceuticals Inc Risk Profiles

Key Fundamentals

InMed Pharmaceuticals Against Markets

Current Ratings  

InMed Pharmaceuticals 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
< 96% 
InMed Pharmaceuticals Inc., a preclinical stage biopharmaceutical company, engages in the research and development of novel and cannabinoidbased therapies in Canada. more
NameInMed Pharmaceuticals Inc
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
Business AddressVancouver, BC VC T
ExchangeOTC Market
BenchmarkDOW
Websitewww.inmedpharma.com
Contact Number604 683 2509
CurrencyUSD - US Dollar

Directors

InMed Pharmaceuticals Corporate Directors
Andrew Hullh Director
Andrew Hull Director
William Garner Director

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas